semaglutide huberman Neuroscientist Dr Andrew discusses the potential use of low-dose GLP-1 receptor agonists for cognitive well-being and neuroprotection. >> See comments 👇 Dr. Andrew Huberman shares his

The effects take place immediately, and for someone who takes a lot of medication, its a lot easier on the bodyespecially on the stomach. [I have a] background in public health, and I can definitely say that through IV therapy youre going to get a lot more benefit getting it through an IV, as opposed to taking something orally

Sitkovsky, M

Wegovy is the FDA-approved brand for chronic weight management and cardiovascular risk reduction (also subcutaneous, at higher dosing)

Using patient reported outcomes in diabetes research and practice: recommendations from a national workshop

Rothhammer et al., 2016)

Microbiota's role in health and diseases